Results 41 to 50 of about 360 (162)

Study of Clinico Pathological Significance of C-Kit Expression in Germ Cell Tumours of Ovary with Special Reference to Dysgerminoma. [PDF]

open access: yes, 2013
Ovaries Are Paired Organs Measuring 4 X 2.5 X 1.5 Cm Each In Dimension1 Situated One On Either Side Of The Uterus Close To Lateral Pelvic Wall. Pathology Of Ovary Is Most Difficult Gynaecological Disease To Evaluate Clinically2.
Mahalakshmi, K
core  

Clear-cell adenocarcinoma (“mesonephroma”) of the vagina.Three cases associated with maternal synthetic nonsteroid estrogen therapy [PDF]

open access: bronze, 1972
Yoshiaki Tsukada   +3 more
openalex   +1 more source

Clinicopathological and Immunohistochemical Profile of Malignant Surface Epithelial Ovarian Tumors. [PDF]

open access: yes, 2013
Ovarian Tumors Are The Most Common Neoplasms In Women. Among The Various Gynecological Tumors, The Pathology Of Ovarian Neoplasms Is More Complex, Because The Ovary Gives Rise To Various Types Of Tumors Than Any Other Organ.
Kuzhalmozhi, M
core  

NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies. [PDF]

open access: yesPathologica, 2022
Marchetti A   +5 more
europepmc   +1 more source

Para-endocrine hypercalcemia in ovarian neoplasms.Report of mesonephroma with hypercalcemia and review of literature [PDF]

open access: bronze, 1971
Alex Ferenczy   +2 more
openalex   +1 more source

Semi-Synthetic Mithramycin Derivatives with Anti-Cancer Activity [PDF]

open access: yes, 2016
Mithramycin derivatives and their pharmaceutically acceptable salts are disclosed. The mithramycin derivatives can be used in the treatment of Ewing sarcoma or other cancer or neuro-disease associated with an aberrant erythroblast transformation ...
Chen, Jhong-Min   +4 more
core   +1 more source

Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study. [PDF]

open access: yesAm J Surg Pathol, 2021
Pors J   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy